# Responsible Side Effects Management in Oncology

> **NCT04623437** · — · COMPLETED · sponsor: **University Hospital Sestre Milosrdnice** · enrollment: 267 (actual)

## Conditions studied

- Pharmacovigilance
- Oncology
- Antineoplastic Treatment

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04623437
- **Lead sponsor:** University Hospital Sestre Milosrdnice
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-01
- **Primary completion:** 2017-09-05
- **Final completion:** 2017-09-05
- **Target enrollment:** 267 (ACTUAL)
- **Last updated:** 2020-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04623437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04623437, "Responsible Side Effects Management in Oncology". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04623437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*